Designing and development of multi-epitope chimeric vaccine against Helicobacter pylori by exploring its entire immunogenic epitopes: an immunoinformatic approach

BACKGROUND: Helicobacter pylori is a prominent causative agent of gastric ulceration, gastric adenocarcinoma and gastric lymphoma and have been categorised as a group 1 carcinogen by WHO. The treatment of H. pylori with proton pump inhibitors and antibiotics is effective but also leads to increased...

Descripción completa

Detalles Bibliográficos
Autores principales: Keshri, Anand K., Kaur, Rimanpreet, Rawat, Suraj S., Arora, Naina, Pandey, Rajan K., Kumbhar, Bajarang V., Mishra, Amit, Tripathi, Shweta, Prasad, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517479/
https://www.ncbi.nlm.nih.gov/pubmed/37740175
http://dx.doi.org/10.1186/s12859-023-05454-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517479/
https://www.ncbi.nlm.nih.gov/pubmed/37740175
http://dx.doi.org/10.1186/s12859-023-05454-2

Ejemplares similares